A few weeks ago I posted about “Sexy baby voice,” the topic of a chapter in Lake Bell’s audiobook about the culture and politics of voices.
Transkribus es una plataforma de reconocimiento de textos escritos que ha demostrado ser muy útil para el trabajo con manuscritos medievales. Tiene dos versiones, Transkribus Lite , un aplicativo web, y Transkribus eXpert , un cliente que se instala en el ordenador, pero cuyas funciones avanzadas se ejecutan en los servidores de Read Coop, la empresa detrás de la plataforma.
I wrote most of this post in June 2022, before a lot of us decided to try out Mastodon. I didn’t publish it because I despaired of it making a difference. It felt like so many people were set in particular practices, including not reading blog posts! My experience on Mastodon has been so much better than the past several years on Twitter. I think this is connected with how Twitter and Mastodon handle threads.
En el irresuelto debate sobe si se deben o no mantener las grafías Et y et –llamadas a veces tironianas, aunque, desde mediados del siglo 14 funcionan como alógrafos de E y e–, el sistema del HSMS, que explico en la sección Normas de transcripción, permite optar por la segunda opción en...
A few days ago, Byron Ahn drew our attention to an excerpt from a new, six-hour audiobook, Inside Voice by Lake Bell, credited as an “actress/writer/director/producer.” Bell is a friend of author and podcaster Malcolm Gladwell, and Gladwell agreed to serve as a kind of sounding board for Bell’s ideas about something she calls “sexy baby voice,” pointing to the voices of Paris Hilton and Kim Kardashian as paradigm examples of it. Gladwell, whose
The construction of gothic cathedrals like Chartres was governed not by blueprints but by “talk, tradition, and templates” — at least that is what Turnbull has compellingly argued. When you come across such a neatly alliterative triad, there are two ways you can go. You can adopt the terms in an unexamined way and rely on their alliterative power.
As many of you know, I have been involved for the past few months in a campaign to get Evusheld – a protective/prophylactic drug for immunocompromised people who do not respond well to Covid vaccines – available on the NHS in the UK. We have not succeeded on that front yet and I am not giving up. However, for my own protection, since AstraZeneca made the drug privately available last week, I have been able to procure it privately.
The other day I wrote about the response that we had from the UK’s Department of Health and Social Care. In that reply the DHSC said that it had a problem with some of the evidence we had put forward because “it should also be noted that most of these studies are pre-prints (therefore have not been scrutinised through peer review)”. A few further notes on this.
This week has been one in which my personal and professional lives have aligned in interesting ways. As you may know, one strand of my work focuses on the study of academic publishing, including peer review. This has featured discussions of the idea of “excellence” but also how preprints are viewed in the world.
There’s a lot of focus in the scholarly communications space on transformative agreements for the mega-publishers. Indeed, most of the discourse, most of the time, is about the big publishers in this space. They play Big Bad Wolf with their exorbitant profit margins and make for an easy target.